FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR ® (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for Hospitalization.
This study has been completed.
Study NCT00270361
Information provided by Scios, Inc.
First Received: December 22, 2005
Last Updated: June 10, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
